Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Solventum Corporation ( (SOLV) ).
On June 25, 2025, Solventum Corporation and Thermo Fisher Scientific Inc. amended their transaction agreement to exclude Solventum’s drinking water filtration business from the acquisition, reducing the purchase price to approximately $4.00 billion. This amendment is expected to simplify the transaction and potentially accelerate its completion by the end of 2025, while retaining the Water Business could enhance Solventum’s earnings per share but may impact projected margin improvements.
The most recent analyst rating on (SOLV) stock is a Buy with a $82.00 price target. To see the full list of analyst forecasts on Solventum Corporation stock, see the SOLV Stock Forecast page.
Spark’s Take on SOLV Stock
According to Spark, TipRanks’ AI Analyst, SOLV is a Outperform.
Solventum Corporation shows strong performance in its earnings call with increased guidance and robust segment growth. However, financial performance is hindered by high leverage and declining cash flow. The technical analysis indicates positive momentum, while valuation suggests the stock might be overvalued. Tariff challenges could impact future profitability.
To see Spark’s full report on SOLV stock, click here.
More about Solventum Corporation
Solventum Corporation operates in the purification and filtration industry, focusing on providing advanced solutions for various filtration needs. The company has a market focus on purification and filtration technologies, excluding its drinking water filtration business.
Average Trading Volume: 1,180,612
Technical Sentiment Signal: Strong Buy
Current Market Cap: $12.67B
See more data about SOLV stock on TipRanks’ Stock Analysis page.